Announcements
Sidley Represents EDBI in Automera’s US$16M Series A Financing
October 2, 2023
Sidley represented EDBI in its investment in Automera, a company developing an autophagy drug designed to target chimera small molecules (AUTACs), in its US$16M Series A financing round.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
連絡先
Offices
得意分野
Suggested News & Insights
Sidley Represents Passport Global in Its US$425 Million Agreement to Be Acquired by Global-e (Nasdaq: GLBE)May 27, 2026Sidley Represents Peach Finance in Its Acquisition by SoFiMay 26, 20262026 Emerging Companies & Venture Capital SummitWednesday, May 20, 2026Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026International Emergency Economic Powers Act Tariff Refund Claims: Key Considerations for Lenders, Borrowers, and Claims PurchasersApril 30, 2026Chambers Global Practice Guides – Corporate M&A 2026April 24, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory